Scott Dalgleish

Chief Financial Officer, Starling Oncology, Inc.

Companies

Starling Oncology, Inc.Chief financial officer Nov 16, 2021 to Mar 29, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Starling Oncology, Inc. STLN151,008 shares²$1.0M at $6.84Mar 21, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 21, 2022Granted 32,092 shares of Starling Oncology, Inc.²
Nov 12, 2021Granted 71,350 shares of Starling Oncology, Inc.³
Nov 12, 2021Granted 47,566 shares of Starling Oncology, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARStarling Oncology, Inc., Chief financial officer
2
SEC EDGARStarling Oncology, Inc. shares after the filing of Mar 21, 2022
3
SEC EDGARForm 4 filed Nov 16, 2021